002A-00 woolly mammoth
Blog Archives
Colossal’s Woolly Mouse Makes His First Christmas Extra Cozy (PEOPLE Exclusive)
Colossal Biosciences released a festive short film, exclusively shared with PEOPLE, starring the company’s woolly mouse as he experiences his […]
Colossal Foundation Raises Additional $50M for Wildlife Recovery
Colossal Foundation has secured another $50 million, doubling its capital to $100 million a little over a year after launch. […]
Interview: Ben Lamm on Hope, Ethics, and Scaling De-Extinction at Colossal Biosciences
In a wide-ranging interview with Dr. Vikas Shah for Thought Economics, Colossal Co-Founder & CEO Ben Lamm discusses how de-extinction […]
Colossal’s Three-Year Plan to Create Cane Toad-Resistant Northern Quolls
Colossal says a single-gene edit could help northern quolls survive toxic cane toads, with the first resistant joeys possible within […]
Interview: Ben Lamm on What’s Next for Colossal Biosciences
International Business Times spotlights Colossal founder Ben Lamm on the company’s next chapter. Since launching in 2021, Colossal has built […]
Colossal Foundation: Drones Reveal Elephants’ Hidden Behaviors
A new Save the Elephants/University of Oxford study—supported by the Colossal Foundation—shows elephants tolerate research drones when flown high and […]
Bringing De-Extinction to the Classroom: How Colossal is Inspiring the Next Generation of Scientists and Conservationists
When middle school teacher feedback reaches Colossal Biosciences about students who once dreamed of becoming influencers now aspiring to be […]
Colossal Biosciences Acquires Viagen Pets & Equin
Colossal Biosciences has completed its first acquisition, bringing Austin-based Viagen Pets & Equine into the company to accelerate species-preservation efforts. […]
Colossal Biosciences Acquires Viagen to Scale Species Recovery
Colossal Biosciences has acquired Viagen Pets & Equine, integrating industry-leading reproductive services, cryopreservation, and cell banking into Colossal’s conservation platform. […]
Colossal’s Billionaire Founder Ben Lamm: From Dire Wolf to What’s Next
In a new interview, billionaire Ben Lamm outlines how Colossal Biosciences is turning headline breakthroughs into a scalable de-extinction platform. […]
